Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma

NCT06594939

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

NCT07563023

Conditions: HIV Associated Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT05728879

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Dermatology CTU Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study

NCT07558057

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Aarhus University Hospital Aarhus, Denmark

View Trial Details

Not Yet Recruiting

Nanobody-Based CD19/CD20 Tandem Dual CAR-T-cell Therapy of Relapsed/Refractory B-Cell Lymphoma

NCT07546630

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP

NCT07552324

Conditions: DHL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

NCT07550634

Conditions: Digestive System Diseases, Hemic and Lymphatic Diseases, Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B), +12 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma

NCT07550855

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Sun Yat-sen Universitiy Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

NCT07497438

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytosis, +9 more
Locations: Intensive Care Unit - Avicenne Hospital, Assistance Publique des Hôpitaux de Paris Bobigny, France

View Trial Details

Not Yet Recruiting

Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)

NCT07548450

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions